Is this you? Create Your Porfile
Avatar

Gillig James Ronald

Eli Lilly and Company

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Gillig James Ronald is active.

Explore More

Publication

Featured researches published by Gillig James Ronald.

Archive | 2016

N-(2-arylethyl)benzylamines as 5-HT6 receptor antagonists

Chen Zhaogen; Cohen Michael Philip; Fisher Matthew Joseph; Giethlen Bruno; Gillig James Ronald; Mccowan Jefferson Ray; Miller Shawn Christopher; Schaus John Mehnert

Archive | 2015

Ν-(2-ΑΡΥΛΑΙΘΥΛΟ)ΒΕΝΖΥΛΑΜΙΝΕΣ ΩΣ ΑΝΤΑΓΩΝΙΣΤΕΣ ΤΟΥ 5-ΗT6 ΥΠΟΔΟΧΕΑ

Chen Zhaogen; Cohen Michael Philip; Fisher Matthew Joseph; Giethlen Bruno; Gillig James Ronald; Mccowan Jefferson Ray; Miller Shawn Christopher; Schaus John Mehnert

Archive | 2007

N-(2-ARYLETHYL) BENZYLAMINE ALS 5-HT6 REZEPTOR-ANTAGONISTE

Chen Zhaogen; Cohen Michael Philip; Fisher Matthew Joseph; Giethlen Bruno; Gillig James Ronald; Mccowan Jefferson Ray; Miller Shawn Christopher; Schaus John Mehnert

Archive | 2007

INDOL-5-IL ESTERES DEL ACIDO BENCENOSULFONICO COMO ANTAGONISTAS DE RECEPTOR 5-HT6.

Filla Sandra Ann; Flaugh Michael Edward; Gillig James Ronald; Heinz Lawrence Joseph; Krushinski Joseph Herman Junio; Liu Bin

Archive | 2006

BENZOLSULFONSÄUREESTER-INDOL-5-YL ALS 5-HT6 REZEPTOR-ANTAGONISTEN

Filla Sandra Ann; Flaugh Michael Edward; Gillig James Ronald; Heinz Lawrence Joseph; Krushinski Joseph Herman; Liu Bin; Pineiro-Nunez Marta Maria; Schaus John Mehnert; Ward Stanley

Archive | 2004

N-(2-ARYLETHYL)BENZYLAMINES AS ANTAGONISTS OF 5-HT6 RECEPTOR, PHARMACEUTICAL COMPOSITION

Cohen Michael Philip; Ficher Matthew Joseph; Gillig James Ronald; Mccowan Jefferson Ray; Miller Shawn Christopher; Schaus John Mehnert

Archive | 2004

Composto, composição farmacêutica, métodos para tratar distúrbios associados com o receptor 5-ht6, distúrbios cognitivos, distúrbios da mémoria, psicose, esquizofrenia, e ansiedade, e, uso de um composto

Chen Zhaogen; Cohen Michael Philip; Fisher Mathew Joseph; Giethlen Bruno; Gillig James Ronald; Mccowan Jefferson Ray; Miller Shawn Christopher; Schaus John Mehnert

Archive | 2004

N-(2-ARYLETHYL)BENZYLAMINES AS ANTAGONISTS OF THE 5-HT6 RECEPTOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Chen Zhaogen; Cohen Michael Philip; Fisher Matthew Joseph; Giethlen Bruno; Gillig James Ronald; Mccowan Jefferson Ray; Miller Shawn Christopher; Schaus John Mehnert

Archive | 2003

N-(2-aryletyl)benzylaminer som antagonister av 5-HT6-reseptoren

Chen Zhaogen; Cohen Michael Philip; Fisher Matthew Joseph; Giethlen Bruno; Gillig James Ronald; Mccowan Jefferson Ray; Miller Shawn Christopher; Schaus John Mehnert

Archive | 2003

N-(2-ARYLETHYL)BENZYLAMINES AS ANTAGONISTS OF THE 5-HT6.

Chen Zhaogen; Cohen Michael Philip; Fisher Matthew Joseph; Giethlen Bruno; Gillig James Ronald; Mccowan Jefferson Ray; Miller Shawn Christopher; Schaus John Mehnert

Explore More

Collaboration

Dive into the Gillig James Ronald's collaboration.

Top Co-Authors
Avatar

Schaus John Mehnert

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Cohen Michael Philip

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Mccowan Jefferson Ray

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Miller Shawn Christopher

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Chen Zhaogen

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Fisher Matthew Joseph

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Giethlen Bruno

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Flaugh Michael Edward

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Krushinski Joseph Herman

Eli Lilly and Company

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge